Literature DB >> 24610537

Salivary bicarbonate as a major factor in the prevention of upper esophageal mucosal injury in gastroesophageal reflux disease.

Tomasz Skoczylas1, Harathi Yandrapu, Cezary Poplawski, Mazen Asadi, Grzegorz Wallner, Jerzy Sarosiek.   

Abstract

BACKGROUND: It has been previously demonstrated that the exposure of the lower esophageal mucosa to acid and pepsin results in significant increase in salivary protective factors secretion, mediated by the esophago-salivary reflex. The impact of the upper esophageal mucosal exposure to acid and pepsin on salivary secretory response remains unknown. AIMS: To investigate the rate of salivary protective factors secretion during the upper esophageal mucosal exposure to acid and pepsin and to compare with the corresponding results recorded during the lower esophageal mucosal exposure, in the same group of asymptomatic volunteers.
METHODS: The study was conducted in 10 asymptomatic volunteers. Salivary samples were collected during the esophageal mucosal exposure to saline, followed by acid/pepsin and the final saline, using the esophageal perfusion catheter. Salivary bicarbonate and non-bicarbonate buffers were analyzed using TitraLab. Salivary mucin and protein were quantified through PAS and Lowry methodologies, respectively, whereas PE2 using radioimmunoassay. Statistical analysis was performed using Σ-Stat software.
RESULTS: The rate of salivary bicarbonate secretion was significantly higher (3.1-fold) during the upper versus the lower esophageal mucosal exposure to acid and pepsin (87.5 ± 14.4 vs. 28.0 ± 7.70 μEq/min, p < 0.05). The volumes of saliva, pH, salivary protein, mucin and PE2 were similar in both esophageal perfusions.
CONCLUSIONS: Threefold stronger secretion of salivary bicarbonate could be a major factor protecting the upper esophageal mucosa. This phenomenon may represent an ultimate defense mechanism potentially preventing further complications within the upper esophageal mucosa; however, it needs to be confirmed in patients of gastroesophageal reflux disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24610537     DOI: 10.1007/s10620-014-3099-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  28 in total

1.  Chemosensitive vagal endings in the oesophagus of the cat.

Authors:  R Harding; D A Titchen
Journal:  J Physiol       Date:  1975-05       Impact factor: 5.182

2.  Differential sensitivity to bradykinin of esophageal distension-sensitive mechanoreceptors in vagal and sympathetic afferents of the opossum.

Authors:  J N Sengupta; J K Saha; R K Goyal
Journal:  J Neurophysiol       Date:  1992-10       Impact factor: 2.714

3.  Modulatory effect of esophageal intraluminal mechanical and chemical stressors on salivary prostaglandin E2 in humans.

Authors:  Z Namiot; Z J Yu; R Piascik; D P Hetzel; R W McCallum; J Sarosiek
Journal:  Am J Med Sci       Date:  1997-02       Impact factor: 2.378

4.  Activity of lingual, laryngeal and oesophageal receptors in conscious sheep.

Authors:  M Falempin; J P Rousseau
Journal:  J Physiol       Date:  1984-02       Impact factor: 5.182

5.  Pepsin 1 secretion in chronic peptic ulceration.

Authors:  V Walker; W H Taylor
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

Review 6.  Effects of acid on the larynx of the maturing rabbit and their possible significance to the sudden infant death syndrome.

Authors:  R F Wetmore
Journal:  Laryngoscope       Date:  1993-11       Impact factor: 3.325

7.  Diminished luminal release of esophageal epidermal growth factor in patients with reflux esophagitis.

Authors:  R M Rourk; Z Namiot; M C Edmunds; J Sarosiek; Z Yu; R W McCallum
Journal:  Am J Gastroenterol       Date:  1994-08       Impact factor: 10.864

8.  Evidence on secretion of epidermal growth factor by the esophageal mucosa in humans.

Authors:  J Sarosiek; D P Hetzel; Z Yu; R Piascik; L Li; R M Rourk; R W McCallum
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

9.  Proximal esophageal pH-metry in patients with 'reflux laryngitis'.

Authors:  P Jacob; P J Kahrilas; G Herzon
Journal:  Gastroenterology       Date:  1991-02       Impact factor: 22.682

10.  Human esophageal secretion: mucosal response to luminal acid and pepsin.

Authors:  Z Namiot; J Sarosiek; R M Rourk; D P Hetzel; R W McCallum
Journal:  Gastroenterology       Date:  1994-04       Impact factor: 22.682

View more
  3 in total

1.  Role of saliva in esophageal defense: implications in patients with nonerosive reflux disease.

Authors:  Harathi Yandrapu; Marek Marcinkiewicz; Cezary Poplawski; Kyung Han; Tomasz Zbroch; George Goldin; Irene Sarosiek; Zbigniew Namiot; Jerzy Sarosiek
Journal:  Am J Med Sci       Date:  2015-05       Impact factor: 2.378

2.  Identification of key pathways and genes in Barrett's esophagus using integrated bioinformatics methods.

Authors:  Cong Zhang; Yujie Shen; Jiazheng Wang; Mingxia Zhou; Yingwei Chen
Journal:  Mol Med Rep       Date:  2017-12-12       Impact factor: 2.952

Review 3.  NETs Are Double-Edged Swords with the Potential to Aggravate or Resolve Periodontal Inflammation.

Authors:  Ljubomir Vitkov; Bernd Minnich; Jasmin Knopf; Christine Schauer; Matthias Hannig; Martin Herrmann
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.